Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Large prostates link to more hair loss.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Certain drugs that block specific enzymes can help treat prostate diseases.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

No link between hair loss severity and PSA levels in men.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

There is no link between hair loss and prostate enlargement.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Testosterone therapy increases bone density in older men with low testosterone levels.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.